15.88BMarket Cap
613.23P/E TTM
JAZZ Balance Sheet
You can check out the annual or quarterly balance sheets of Jazz Pharmaceuticals PLC here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
FAQs
Which balance sheet metrics matter most when analyzing JAZZ stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does Jazz Pharmaceuticals PLC Have?
In its most recent quarterly, Jazz Pharmaceuticals PLC had 1.84B in cash and cash equivalents.
How Much Are Jazz Pharmaceuticals PLC's Total Liabilities?
Jazz Pharmaceuticals PLC reported 7.34B in total liabilities as of the latest reported quarter, including 2.24B in current liabilities and 5.10B in non-current liabilities.
What Are Jazz Pharmaceuticals PLC's Total Assets?
As of the latest reported quarter, Jazz Pharmaceuticals PLC's total assets were 11.66B, consisting of 4.17B in current assets and 7.49B in non-current assets.
How Much Shareholders' Equity Does Jazz Pharmaceuticals PLC Have?
Jazz Pharmaceuticals PLC reported 4.32B in total shareholders' equity as of the latest reported quarter.